Nutramax Laboratories researches, develops, and markets high-quality products to support the active lifestyles of people and animals. The company’s flagship products include the Cosamin® and Cosequin® joint health supplements. Nutramax Laboratories’ products are sold in food and drug stores, mass retailers, warehouse club stores, veterinarians, pet specialty retailers and online.

K&L Microwave is a subsidiary of Dover Corporation, a $7.5 billion Fortune 400 company traded on the New York Stock Exchange, recognized by top-tier defense contractors and wireless infrastructure providers as a world leader in the design and manufacture of RF and microwave filters, duplexers and integrated assemblies. K&L is AS9100 and ISO 14001 certified and offers customers the most extensive range of filter-based products in the industry, spanning from 0.3MHz to 94GHz.

K&L began operations over 40 years ago in a 1,400 square foot facility manufacturing custom filters primarily for the military sector. Today, with manufacturing facilities in the United States and the Dominican Republic and a global sales presence, K&L is the industry’s premier filter supplier for both military and commercial markets. Over 410 employees represent the engineering, sales and marketing, manufacturing and support personnel that enable K&L to support such a broad product and customer base.

Black & Decker has been setting the standard for home improvement products since 1910. With roots in Baltimore, Maryland, the company evolved from a small machine shop that invented the first portable electric drill to a global manufacturing and marketing powerhouse. Black & Decker’s product line now includes a broad variety of products for both commercial and residential use.

Sterilex is a recognized industry leader for developing innovative, award-winning solutions for microbial control. The company markets a line of proprietary, award winning biofilm-control biocides, broad spectrum disinfectants and rapid biofilm diagnostic tools that can be used for a variety of applications, including food and beverage protection, animal health, and water treatment applications.

Hughes Network Systems LLC (HUGHES) is a global leader in broadband satellite technology and services for home and office. Its flagship high-speed satellite Internet service is HughesNet®, the world’s largest satellite network, with over 1 million residential and business customers across North America and Brazil.

For large enterprises and governments, the company’s HughesON® managed network services provide complete connectivity solutions, employing an optimized mix of satellite and terrestrial technologies. The company’s JUPITER™ System is the world’s most widely deployed High-Throughput Satellite (HTS) platform, operating on more than 20 satellites by leading service providers, delivering a wide range of broadband enterprise, mobility and cellular backhaul applications.

To date, Hughes has shipped more than 5.5 million terminals to customers in over 100 countries, representing an approximately 50 percent market share, and its technology is powering broadband services to aircraft around the world.

With annual revenues of over $1 billion, Hughes’ headquarters are in Germantown, Md., although the company has offices in 11 countries and customers in over 100 countries.

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular & Metabolic Diseases, and Infection and Vaccines. MedImmune is headquartered in Gaithersburg, Md., one of AstraZeneca’s three global R&D centers, with additional sites in Cambridge, UK and Mountain View, Calif.

MedImmune’s SYNAGIS therapeutic is an FDA-approved prescription injection of antibodies that is given monthly to help protect high-risk infants from severe respiratory syncytial virus, or RSV.

RSV is a common virus that, like the flu, is seasonal and easily spread. Most children will get RSV by the age of two. RSV begins with cold-like symptoms but can spread to the lungs. For babies with certain health conditions, RSV can be very serious.

SYNAGIS is the first monoclonal antibody approved for the prevention of an infectious disease, as well as the first such drug to be safely used in children.